NCT06685523 Evaluation of Fractalkine and Its Receptor in Peri-implantitis
| NCT ID | NCT06685523 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kubilay BARIŞ |
| Condition | Peri-implantitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-11-08 |
| Primary Completion | 2025-05-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-11-08 with a primary completion date of 2025-05-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, mechanical debridement group, Er:YAG laser group and diode laser group will be compared in terms of reducing peri-implant sulcus depth in the treatment of peri-implantitis.
Eligibility Criteria
Inclusion Criteria: * Probing depth of 4-6 mm, bone loss of at least 2 mm on X-ray and presence of inflammatory symptoms in soft tissue * No systemic disease that may affect the outcome of the treatment * Patients with healthy periodontium or patients with completed periodontal treatment * Individuals at least 6 months after prosthesis loading on the implant * Individuals who do not require further surgery for the treatment of peri-implantitis * Implants with at least 2 mm keratised gingiva * Individuals aged 40-60 years Exclusion Criteria: * Individuals undergoing radiation therapy * Individuals who smoke and drink alcohol * Individuals in pregnancy or lactation * Individuals who have received antibiotic treatment in the last three months * Individuals with parafunctional habits
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06685523 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Peri-implantitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06685523 currently recruiting?
Yes, NCT06685523 is actively recruiting participants. Contact the research team at kubilaybaris60@hotmail.com for enrollment information.
Where is the NCT06685523 trial being conducted?
This trial is being conducted at Kirikkale, Turkey (Türkiye).
Who is sponsoring the NCT06685523 clinical trial?
NCT06685523 is sponsored by Kubilay BARIŞ. The trial plans to enroll 100 participants.